Godavari Drugs Ltd
company logo

Godavari Drugs Ltd

Godavari Drugs Share Price

Pharmaceuticals
Small Cap

-

0 (0%)

Invest in Godavari Drugs Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Godavari Drugs Ltd Performance

-

-

-

-


-

-

-

-

-

Godavari Drugs Ltd Fundamentals

Read More

85.54Cr

12.82

2.05

1.59

8.86

0%

55.36

Godavari Drugs Ltd Financials

Godavari Drugs Ltd Financialsright-arrow

Godavari Drugs Ltd Shareholding Pattern

Godavari Drugs Ltd Delivery and Volume

About Godavari Drugs Ltd

Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India.. Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoyi

Mukund Kakani

1987

-

NameDesignation
Mukund KakaniManaging Director
S A HussainNon-Exec. & Independent Dir.
Mohit JajuWhole Time Director & CFO
Vimala B MadonNon-Exec. & Independent Dir.
Ghanshyam JajuChairman (Non-Executive)
Mahindra Uday BhaleraoNon Executive Director
Dinesh UdpaIndependent Director
Venkatesh AchantaCompany Sec. & Compli. Officer
News and Events...

Similar Stocks

What's Trending

View All
View All

Godavari Drugs Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Godavari Drugs Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Godavari Drugs Ltd's share price is ₹113.6 as of 2024-11-27.
Godavari Drugs Ltd's P/E ratio is 12.82 times as of 2024-11-27.
Godavari Drugs Ltd's most recent financial reports indicate a price-to-book ratio of 2.05, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Godavari Drugs Ltd's market capitalization is ₹85.54 Cr as on 2024-11-27.
The current financial records of Godavari Drugs Ltd show a 15.33% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Godavari Drugs Ltd's most recent financial filings, the company has a total asset value of ₹88.48, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Godavari Drugs Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Godavari Drugs Ltd's 52-week high and low as of 2024-11-27 are ₹115.8 and ₹110, respectively.